Pittsburgh and Epworth Sleep Scale Items: Accuracy of Ratings Across Different Reporting Periods.

a Department of Psychiatry and Behavioral Science , Stony Brook University.
Behavioral Sleep Medicine (Impact Factor: 1.74). 01/2012; DOI: 10.1080/15402002.2012.654549
Source: PubMed

ABSTRACT This study examined the ecological validity of sleep experience reports across different lengths of reporting periods. The accuracy of item responses on the Pittsburgh Sleep Quality Index (PSQI) and Epworth Sleepiness Scale (ESS) across 3-, 7-, and 28-day reporting periods was examined in relation to electronic daily item ratings. Primary care clinic patients (N = 119) were recruited, and were not required to have sleep problems to participate. Analyses found few differences in item scores when electronic daily ratings were compared with recall ratings, regardless of the length of the reporting period. However, within-subjects analyses indicated low levels of accuracy in recall of sleep items for specific days in the last week. Thus, for the purpose of between-subject comparisons, patients generally can provide accurate recall of sleep experiences; studies requiring finer-grained analysis across time and within-subjects require daily diary methodology.

  • [Show abstract] [Hide abstract]
    ABSTRACT: To assess the influence of craniopharyngioma or consequent surgery on melatonin secretion, and the association with fatigue, sleepiness, sleep pattern and -quality. Cross-sectional study. Fifteen craniopharyngioma patients were individually matched to healthy controls. 24h-salivary melatonin and cortisol were measured. Sleep-wake patterns were characterized by actigraphy and sleep diaries recorded for two weeks. Sleepiness, fatigue, sleep quality, and general health were assessed by Multidimensional Fatigue Inventory, Pittsburgh Sleep Quality Index, Epworth Sleepiness Score, and Short Form-36. Patients had increased mental fatigue, daytime dysfunction, sleep latency, lower general health (all, p≤0.05), and tended to have increased daytime sleepiness, general fatigue, and impaired sleep quality compared to controls. The degree of hypothalamic injury was associated with increased body mass index (BMI) and lower mental health (p=0.01). High BMI was associated with increased daytime sleepiness, daytime dysfunction, mental fatigue, and lower mental health (all, p≤0.01). Low midnight melatonin was associated with reduced sleep time and efficiency (p≤0.03) and a tendency to increased sleepiness, impaired sleep quality, and physical health. Midnight melatonin remained independently related to sleep time after adjustment for cortisol. Three different patterns of melatonin profiles were observed; normal (n=6), absent midnight peak (n=6), and phase shifted peak (n=2). Only patients with absent midnight peak had impaired sleep quality, increased daytime sleepiness, general and mental fatigue. Craniopharyngioma patients present changes in circadian pattern and daytime symptoms, which may be due to the influence of the craniopharyngioma or its treatment on the hypothalamic circadian and sleep regulatory nuclei.
    European Journal of Endocrinology 03/2014; · 3.69 Impact Factor
  • Source
    Value in Health 09/2014; · 2.89 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The identification of the gene mutation causing Huntington disease has raised hopes for new treatments to ease symptoms and slow functional decline. As such, there has been a push towards designing efficient pharmacological trials (i.e., drug trials), especially with regard to selecting outcomes measures that are both brief and sensitive to changes across the course of the disease, from subtle prodromal changes, to more severe end-stage changes.
    Journal of Huntington's disease. 01/2014; 3(3):233-52.


Available from
May 17, 2014